Service is in preparation Official β release coming soon. Some features are still being adjusted.

Investical Earnings & investing calendar Earnings & investing calendar
/
CCHUKYO IYAKUHIN CO.,LTD. logo
4558TSE Standard

CHUKYO IYAKUHIN CO.,LTD.

中京医薬品 Yahoo Finance

Recent & upcoming events

Aug 5
Earnings 2:00
Q1 earnings announcement (scheduled)
Add to Google Calendar
Jun 24
Shareholder meeting 21:30
Shareholders' meeting
Venue: 知多信用金庫本店営業部 3階 ほしざきホール 愛知県半田市星崎町三丁目39番地の10 Details
Add to Google Calendar
May 13
Earnings 2:00
FY earnings announcement (scheduled)
Add to Google Calendar
Sep 27
Est.
Dividend Time TBD
Last day with rights (interim)
Add to Google Calendar
Sep 28
Est.
Ex-dividend Time TBD
Ex-rights date (interim)
Add to Google Calendar
Nov 5
Earnings 1:00 approx.
Q2 earnings announcement (scheduled)
Add to Google Calendar
2027
Feb 5
Earnings 1:00 approx.
Q3 earnings announcement (scheduled)
Add to Google Calendar
Mar 28
Est.
Dividend Time TBD
Last day with rights (year-end)
Add to Google Calendar
Mar 29
Est.
Ex-dividend Time TBD
Ex-rights date (year-end)
Add to Google Calendar
May 5
Est.
Earnings 2:00 approx.
Full-year earnings
Add to Google Calendar
Aug 11
Est.
Earnings 2:00 approx.
Q1 earnings
Add to Google Calendar

KPI highlights

FY26
Revenue ¥6.57B YoY +4.2%
Operating income ¥127M margin 1.9%
Net income ¥84M YoY +85.2%
EPS —
P/E —
ROE —

Company guidance

FY2027/03 Company-issued full-year guidance (from earnings report) / %=vs prior FY
Revenue ¥6.15B -6.4%
Operating income ¥133M +4.4%
Net income ¥85M +1.7%
EPS ¥8 —

Quarterly fundamentals

Income & cash flow
Quarter FY22 Q4FY23 Q1FY23 Q2FY23 Q3FY23 Q4FY24 Q1
Revenue ¥1.66B¥1.21B¥1.64B¥1.47B¥1.80B¥1.21B
Operating income ¥177M¥-136M¥89M¥-31M¥229M¥-158M
Net income ¥114M¥-100M¥56M¥-114M¥151M¥-120M
Operating CF ——————

Ownership over time

Share of total shares outstanding (disclosed major holdings + undisclosed)（2021–2026）

事業法人 14.9%国内機関 6.8%個人 10%未開示 68.3%202120222023202420252026
事業法人国内機関海外機関個人未開示・浮動株

「国内機関」は信託銀行の名義口座（年金・パッシブ・一部海外資本を含む）を集計し、実質保有者へは分解していません。分類は開示名称からの推定です。

Top shareholders — rank & share

株式会社マサユキコーポレーション 14.9%株式会社マサユキコーポレーション山田　正行 3.1%山田　正行早乙女　修司 2.7%早乙女　修司知多信用金庫 1.8%知多信用金庫JPモルガン証券株式会社 1.8%JPモルガン証券株式会社株式会社日本カストディ銀行（信託口） 1.8%株式会社日本カストディ銀行（信託口）中京医薬品従業員持株会（きずな会） 1.5%中京医薬品従業員持株会（きずな会）杉浦　直幸 1.4%杉浦　直幸株式会社三菱ＵＦＪ銀行 1.4%株式会社三菱ＵＦＪ銀行山田　正人 1.3%山田　正人202120222023202420252026

Top shareholders — actual figures (as of 2026)

Holder Shares held Ratio Source
株式会社マサユキコーポレーション 1,625,000 14.9% Yuho (EDINET)
山田 正行 334,000 3.1% Yuho (EDINET)
早乙女 修司 289,000 2.7% Yuho (EDINET)
知多信用金庫 200,000 1.8% Yuho (EDINET)
JPモルガン証券株式会社 198,000 1.8% Yuho (EDINET)
株式会社日本カストディ銀行（信託口） 197,000 1.8% Yuho (EDINET)
中京医薬品従業員持株会（きずな会） 161,000 1.5% Yuho (EDINET)
杉浦 直幸 153,000 1.4% Yuho (EDINET)
株式会社三菱UFJ銀行 150,000 1.4% Yuho (EDINET)
山田 正人 145,000 1.3% Yuho (EDINET)

Source：EDINET（大株主の状況）　Classification inferred from disclosed names

F-Score (Piotroski)

3/9 4 of 9 items lack data

Checks financial health against 9 criteria and shows how many are met as a fraction (more ✓ marks is healthier). Items with no data are shown as “—” — they're simply excluded from judgment, not counted against the score.

✓ Positive ROA ROA 1.6%
— Positive operating cash flow No data
✓ ROA improved YoY 0.9% → 1.6%
— Operating CF exceeds net income (accrual quality) No data
✗ Equity ratio improved* Substitute for the original “decrease in long-term debt” 49.9% → 48.8%
— Current ratio improved No data
✓ No dilution (shares outstanding did not increase) 11,660,000 → 11,660,000
— Gross margin improved No data
✗ Asset turnover improved 1.25× → 1.24×

This score is reference information based on our own financial metrics. It is NOT a credit rating issued by a credit rating agency under Article 66-27 of the Financial Instruments and Exchange Act, and is NOT investment advice or a recommendation. Make investment decisions at your own responsibility.

Fact checklist

FY26
Equity ratio —
Current ratio —
Years of positive operating CF 4 of last 6 yrs
Payout ratio 64%
Latest fiscal year result Profit (net income ¥84M)

Performance history

Last 10 years
0億円16億円33億円49億円66億円 FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26

Income & assets

Unit: ¥100M
Item FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
Revenue 58.754.952.651.758.353.656.961.263.165.7
Operating income 1.150.550.060.712.260.640.601.281.061.27
Ordinary income 1.340.720.260.872.380.840.801.481.171.40
Net income 0.490.120.290.100.950.330.14-0.270.450.84
Total assets 46.545.445.644.251.753.452.450.850.752.9
Equity 18.518.318.218.024.526.225.825.225.325.8

Indicators & cash flow

Unit: ¥100M
Item FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
EPS ———¥1¥10¥3¥1¥-3¥4—
ROE ——————————
Operating CF ———0.341.99-1.13-0.271.030.69—
Investing CF ———-0.460.770.49-0.21-0.340.53—
Financing CF ———-0.294.082.81-2.31-1.150.62—
FCF ———0.263.22-2.70-0.861.350.06—

A “—” means data wasn't available for that period — it's not a display error or an unusual value.

Source: EDINET (Annual Securities Report) (fetched 2026-08-29) *Some metrics supplemented from additional sources

Key financial metrics

3-year revenue growth ✓

Sector positioning

Relative standing within the sector
Is this information incorrect?

Data provided by Twelve Data